Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab. Crosby S, Schuh MJ, Farraye FA. J Crohns Colitis 2021;15:871.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Crosby S, Schuh MJ, Farraye FA. Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab. J Crohns Colitis 2021;15:871.
PMID: 33016326